|Description||Health Care Sector Investing|
|Biomed Fund II, 12/11||€40M|
EMBL Ventures is an independent venture capital investor that engages in the financing and development of first-in-class products and technologies in the healthcare sector. Based on a strong scientific pedigree, the Fund strategy combines the core competencies of “Pharma” and “Biotech” to arrive at a scalable investment model that seeks at creating commercial value.
|Allecra Therapeutics||4/13||Series A||€15M||3|
|ELARA Pharmaceuticals||11/09||Series A||$6.91M||3|
|immatics biotechnologies||4/05||Series B||$7.5M||7|